Fluorinated phenytoin anticonvulsant analogs

Area of Science:

• Medicinal Chemistry
• Neuropharmacology

Background:

• Phenytoin is a widely used anticonvulsant medication.
• Developing novel anticonvulsant agents with improved properties is an ongoing area of research.

Purpose of the Study:

• To synthesize and evaluate the anticonvulsant activity of novel ring-fluorinated phenytoin analogs.
• To compare the efficacy and duration of action of these analogs with the parent compound, phenytoin.

Main Methods:

• Synthesis of six ring-fluorinated phenytoin analogs.
• Anticonvulsant activity screening using the maximal electroshock seizure (MES) assay.
• Anticonvulsant activity screening using the subcutaneous pentylenetetrazol (scPTZ) assay.

Main Results:

• Three synthesized analogs demonstrated activity in the MES assay.
• The active compounds were 5-(4-Fluorophenyl)-5-phenylhydantoin, 5-(3-fluorophenyl)-5-phenylhydantoin, and 5,5-bis(4-fluorophenyl)hydantoin.
• These analogs exhibited significantly lower potency compared to phenytoin but possessed an exceptionally long duration of action.

Conclusions:

• Ring-fluorination of phenytoin can yield analogs with anticonvulsant properties.
• While less potent, these analogs offer a prolonged duration of action, suggesting potential for specific therapeutic applications.
• Further investigation into the pharmacokinetic and pharmacodynamic profiles of these compounds is warranted.